Cardiometabolic Medical Science Liaison

Role: Cardiometabolic Medical Science Liaison (MSL) within Medical Affairs, focusing on supporting clinical stage and launch activities for RNAi-based therapeutics targeting hypertriglyceridemia and familial chylomicronemia syndrome. Responsibilities include engaging healthcare professionals (cardiologists, endocrinologists) through scientific exchanges, educating on RNAi technology and indications, supporting clinical trial sites, and disseminating scientific insights. The role involves attending scientific congresses, monitoring literature and competitive landscape, developing educational content, and collaborating with internal teams through sophisticated stakeholder management. Requirements: PhD, PharmD, MD, or DO; 5+ years as an MSL with cardiometabolic experience; strong communication, scientific interpretation, and project management skills; industry experience in biotech or pharma medical affairs; ability to travel. High-value: cardiometabolic (hypertriglyceridemia, familial chylomicronemia, hypercholesterolemia), therapeutic area expertise, support for clinical trials, stakeholder engagement in real-world settings, and scientific education. Work setup: field-based position within a specified territory; travel required.